This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,846.64 firm fixed-price delivery order is for the supply of NovoSeven RT 2 mg vials, a specialty medication. This award is a part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This delivery order, with a performance period through December 23, 2024, demonstrates AmerisourceBergen's role as a key vendor for federal healthcare procurement, particularly within the military and veterans' healthcare systems.
Generated 3/9/25, 12:54 AM